bioAffinity Technologies, Inc. filed a Form 8-K on September 22, 2026, disclosing that the company issued a press release announcing the presentation of two posters on its CyPath® Lung diagnostic at the 2026 NAVREF Annual Conference, scheduled for September 27-30, 2026, in Arlington, Virginia.
Columbus McKinnon Corporation filed a current report on Form 8-K on September 22, 2026, disclosing that it entered into a First Amendment to its Credit Agreement on September 21, 2026, refinancing its Term Loan B Facility and reducing the applicable interest rate margin on …
iPower Inc. filed a Form 8-K on September 22, 2026, disclosing the voting results from a special meeting of stockholders held on September 21, 2026, at which shareholders approved three proposals covering a stock offering authorization, a reverse stock split, and an amended equity …
Upbound Group, Inc. filed an 8-K with the SEC on September 22, 2026, disclosing the appointment of Scott Young as Executive Vice President and Chief Operating Officer, effective the same date.
Madison Square Garden Sports Corp. filed an 8-K on September 22, 2026, disclosing executive officer changes effective September 21, 2026, including the appointment of Jamaal T. Lesane as Executive Vice President and Chief Legal Officer.
Lucid Diagnostics Inc. filed a Form 8-K with the SEC on September 22, 2026, disclosing that it issued a press release announcing advances in payment, billing, and coding pathways for its EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device.
Caesars Entertainment, Inc. filed an 8-K on September 22, 2026, reporting that it received a stockholder demand letter on September 15, 2026, and voluntarily supplemented its definitive proxy statement to address allegations concerning its outside legal counsel's concurrent representations.
Piper Sandler Companies filed a Form 8-K on September 22, 2026, disclosing the election of Wendy L. Schoppert to its Board of Directors, effective that same date.
Brand Engagement Network Inc. filed a Form 8-K on September 22, 2026, disclosing that it entered into a Securities Purchase Agreement on September 21, 2026, for a private placement of common stock and warrants generating total gross proceeds of $1,051,025.00.
Nuburu, Inc. filed an amended quarterly report on Form 10-Q/A on September 22, 2026, restating its financial statements for the three and six months ended June 30, 2026, to correct a misstatement related to the fair value calculation of the Tekne Convertible Note Receivable.